A couple of points:
I posted this earlier....
It is reasonable to expect the early adopters are ordering the 5.47 to 3.92 orders per base physician per Qtr. Furthermore given the positive results and "vibe" of the XPAND trial that a cohort of the authors are said early adopters.
In respect of the anecdotal information on institutions selling down and others buying up, there has only been one change in substantial shareholder notice; on 12 April just after this saga started.
FYI Rules..... http://download.asic.gov.au/media/1236706/rg5-published-20-december-2013.pdf
btw... I have one AXP trade (of many) "in the money"!!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 29583410 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 59394450 | 39 |
View Market Depth
| Last trade - 16.13pm 20/06/2025 (20 minute delay) ? |
| AXP (ASX) Chart |
Day chart unavailable